Automation on an Open-Access Platform of Alzheimer’s Disease Biomarker Immunoassays

The lack of (inter-)laboratory standardization has hampered the application of universal cutoff values for Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers and their transfer to general clinical practice. The automation of the AD biomarker immunoassays is suggested to generate more robu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	SLAS technology 2018-04, Vol.23 (2), p.188-197
Hauptverfasser:	Gille, Benjamin, Dedeene, Lieselot, Stoops, Erik, Demeyer, Leentje, Francois, Cindy, Lefever, Stefanie, De Schaepdryver, Maxim, Brix, Britta, Vandenberghe, Rik, Tournoy, Jos, Vanderstichele, Hugo, Poesen, Koen
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - diagnosis Amyloid beta-Peptides - cerebrospinal fluid Automation, Laboratory - methods Biomarkers - cerebrospinal fluid Cerebrospinal Fluid - chemistry Feasibility Studies Humans Immunoassay - methods tau Proteins - cerebrospinal fluid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!